×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Portfolio Management in Pharma: Strategies and Insights from Large, Medium, and Small Pharma Organizations
Session Chair(s)
Erin Mulrooney, MSc, PMP
Director, Portfolio Management
Daiichi Sankyo, Inc, United States
This panel discussion explores the diverse strategies employed by organizations in managing their portfolio across the value chain. Experts will discuss how systems, tools, benchmarks and visualizations are utilized to enhance decision-making.
Learning Objective : Describe the different Portfolio Management approaches used across the pharmaceutical value chain in organizations of varying size; Outline success factors for effective Portfolio Management within your own organization.
Speaker(s)
Biotech Perspective
Christine Mears, MA
Generate BioMedicines, United States
Executive Director, Portfolio Management
Rare Disease Industry Perspective
Katie Bloom
Ultragenyx, United States
Executive Director, Co-Head of PMO, Program Management Office
Large Pharma Industry Perspective
Rosa Tarng, MA
Takeda, United States
Translational Program Management
Have an account?